All In MedTech

FDA Clearance Tracker · P830079-S016

INSTAT COLLAGEN HEMOSTAT

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 22, 2005 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 22, 2005

Approved

Time to decision

28 days

Received Jun 24, 2005. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P830079-S016
Device name
INSTAT COLLAGEN HEMOSTAT
Applicant
ETHICON, Inc.
Applicant location
Somerville, NJ
Received
Jun 24, 2005
Decided
Jul 22, 2005
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P830079

Device type

Device class
Class III
Regulation
21 CFR 878.4490

Every decision under product code LMF

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A STERILIZATION SITE LOCATED AT STERIS ISOMEDIX SERVICES, WHIPPANY, NEW JERSEY.

Source documents

Other decisions for ETHICON, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.